Annual Accounts Payable
$9.11 M
+$4.29 M+89.06%
30 April 2024
Summary:
KalVista Pharmaceuticals annual accounts payable is currently $9.11 million, with the most recent change of +$4.29 million (+89.06%) on 30 April 2024. During the last 3 years, it has risen by +$7.13 million (+359.72%). KALV annual accounts payable is now at all-time high.KALV Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$10.79 M
+$1.69 M+18.50%
31 July 2024
Summary:
KalVista Pharmaceuticals quarterly accounts payable is currently $10.79 million, with the most recent change of +$1.69 million (+18.50%) on 31 July 2024. Over the past year, it has increased by +$5.90 million (+120.42%). KALV quarterly accounts payable is now at all-time high.KALV Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KALV Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +89.1% | +120.4% |
| 3 y3 years | +359.7% | +241.6% |
| 5 y5 years | +218.4% | +382.2% |
KALV Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +359.7% | at high | +535.6% |
| 5 y | 5 years | at high | +443.1% | at high | +1583.6% |
| alltime | all time | at high | +6095.2% | at high | +5671.1% |
KalVista Pharmaceuticals Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| July 2024 | - | $10.79 M(+18.5%) |
| Apr 2024 | $9.11 M(+89.1%) | $9.11 M(+193.7%) |
| Jan 2024 | - | $3.10 M(-36.7%) |
| Oct 2023 | - | $4.90 M(-3.2%) |
| July 2023 | - | $5.06 M(+5.0%) |
| Apr 2023 | $4.82 M(+32.4%) | $4.82 M(+183.7%) |
| Jan 2023 | - | $1.70 M(-49.8%) |
| Oct 2022 | - | $3.38 M(+16.4%) |
| July 2022 | - | $2.91 M(-20.1%) |
| Apr 2022 | - | $3.64 M(+66.5%) |
| Apr 2022 | $3.64 M(+83.6%) | - |
| Jan 2022 | - | $2.19 M(-30.8%) |
| Oct 2021 | - | $3.16 M(+118.2%) |
| July 2021 | - | $1.45 M(-26.9%) |
| Apr 2021 | $1.98 M(+18.1%) | $1.98 M(+209.0%) |
| Jan 2021 | - | $641.00 K(-70.5%) |
| Oct 2020 | - | $2.17 M(+22.5%) |
| July 2020 | - | $1.77 M(+5.8%) |
| Apr 2020 | $1.68 M(-41.4%) | $1.68 M(-43.2%) |
| Jan 2020 | - | $2.95 M(+31.9%) |
| Oct 2019 | - | $2.24 M(-27.9%) |
| July 2019 | - | $3.10 M(+8.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Apr 2019 | $2.86 M(+99.6%) | $2.86 M(-4.6%) |
| Jan 2019 | - | $3.00 M(-0.7%) |
| Oct 2018 | - | $3.02 M(+28.7%) |
| July 2018 | - | $2.35 M(+63.6%) |
| Apr 2018 | $1.43 M(+24.3%) | $1.43 M(-9.0%) |
| Jan 2018 | - | $1.57 M(+51.4%) |
| Oct 2017 | - | $1.04 M(-46.5%) |
| July 2017 | - | $1.94 M(+68.5%) |
| Apr 2017 | $1.15 M(+14.4%) | $1.15 M(+52.7%) |
| Jan 2017 | - | $755.00 K(+75.2%) |
| Sept 2016 | - | $431.00 K(+130.5%) |
| June 2016 | - | $187.00 K(-76.4%) |
| Apr 2016 | $1.01 M(-31.0%) | - |
| Mar 2016 | - | $793.00 K(-45.7%) |
| Dec 2015 | $1.46 M(+42.6%) | $1.46 M(-4.4%) |
| Sept 2015 | - | $1.53 M(-23.3%) |
| June 2015 | - | $1.99 M(-21.7%) |
| Mar 2015 | - | $2.54 M(+148.5%) |
| Dec 2014 | $1.02 M(+121.6%) | $1.02 M(-17.2%) |
| Sept 2014 | - | $1.24 M(+167.7%) |
| Dec 2013 | $462.00 K(+214.3%) | $462.00 K |
| Dec 2012 | $147.00 K | - |
FAQ
- What is KalVista Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for KalVista Pharmaceuticals?
- What is KalVista Pharmaceuticals annual accounts payable year-on-year change?
- What is KalVista Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for KalVista Pharmaceuticals?
- What is KalVista Pharmaceuticals quarterly accounts payable year-on-year change?
What is KalVista Pharmaceuticals annual accounts payable?
The current annual accounts payable of KALV is $9.11 M
What is the all time high annual accounts payable for KalVista Pharmaceuticals?
KalVista Pharmaceuticals all-time high annual accounts payable is $9.11 M
What is KalVista Pharmaceuticals annual accounts payable year-on-year change?
Over the past year, KALV annual accounts payable has changed by +$4.29 M (+89.06%)
What is KalVista Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of KALV is $10.79 M
What is the all time high quarterly accounts payable for KalVista Pharmaceuticals?
KalVista Pharmaceuticals all-time high quarterly accounts payable is $10.79 M
What is KalVista Pharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, KALV quarterly accounts payable has changed by +$5.90 M (+120.42%)